Feifei Jiang
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Sensory Systems top 10%
- Ion Channels and Receptors
Papers in
-
- Ion Transport and Channel Regulation 1
- Oncology 5
- Inflammatory Biomarkers in Disease Prognosis 2
- Co-authors
- Ke Cao (1 shared paper)Min Wu (1 shared paper)Xin Li (1 shared paper)Ning Li (1 shared paper)Chuanyun Li (1 shared paper)Dexi Chen (1 shared paper)Xiang Hu (3 shared papers)Feixia Shen (3 shared papers)
- Journals
- Molecular Cancer (1 paper)Oncogene (1 paper)Cardiovascular Diabetology (1 paper)Frontiers in Oncology (1 paper)Oncotarget (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Feifei Jiang
29 papers receiving 759 citations
Feifei Jiang's Hit Papers
Peers
Comparison fields: 5 of 92
- Cancer Research 185
- Sensory Systems 31
- Oncology 163
- Molecular Biology 360
- Hepatology 34
Countries citing papers authored by Feifei Jiang
This map shows the geographic impact of Feifei Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifei Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifei Jiang more than expected).
Fields of papers citing papers by Feifei Jiang
This network shows the impact of papers produced by Feifei Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifei Jiang. The network helps show where Feifei Jiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Feifei Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The significance of exosomes in the development and treatment of hepatocellular carcinoma Hit paper breakdown → | 2020 | 410 |
| 2 | 2022 | 59 | |
| 3 | 2008 | 42 | |
| 4 | 2016 | 35 | |
| 5 | 2017 | 21 | |
| 6 | 2016 | 20 | |
| 7 | 2013 | 18 | |
| 8 | 2014 | 17 | |
| 9 | 2022 | 17 | |
| 10 | 2021 | 16 | |
| 11 | 2016 | 13 | |
| 12 | 2021 | 11 | |
| 13 | 2020 | 11 | |
| 14 | 2017 | 10 | |
| 15 | 2022 | 9 | |
| 16 | 2021 | 8 | |
| 17 | 2021 | 7 | |
| 18 | 2021 | 7 | |
| 19 | [The study on the relationship between human papillomavirus infection and pathogenesis of nasal inverted papilloma and its malignant transformation]. | 2010 | 7 |
| 20 | [Detection and evaluation of serum GP73, a resident Golgi glycoprotein, as a marker in diagnosis of hepatocellular carcinoma]. | 2010 | 5 |
About Feifei Jiang
Feifei Jiang is a scholar working on Molecular Biology, Oncology, Cancer Research, Sensory Systems and Surgery, having authored 31 papers that have together received 766 indexed citations. Recurring topics across this work include Ion Channels and Receptors (4 papers), Inflammatory Biomarkers in Disease Prognosis (2 papers), MicroRNA in disease regulation (2 papers), Phytochemicals and Antioxidant Activities (1 paper), Gestational Diabetes Research and Management (1 paper), Diverse Approaches in Healthcare and Education Studies (1 paper), Ion Transport and Channel Regulation (1 paper) and Endoplasmic Reticulum Stress and Disease (1 paper). The work is most often cited by research in Cancer Research (185 citations), Sensory Systems (31 citations), Oncology (163 citations), Molecular Biology (360 citations) and Hepatology (34 citations). Feifei Jiang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Ke Cao, Min Wu, Xin Li, Ning Li, Chuanyun Li, Dexi Chen, Xiang Hu, Feixia Shen, Jing Hong and Bing Shen. Their work appears in journals such as Molecular Cancer, Oncogene, Cardiovascular Diabetology, Frontiers in Oncology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.